Clinical Efficacy of Remote Monitoring in the Management of Heart Failure
NCT ID: NCT01723865
Last Updated: 2014-08-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
988 participants
OBSERVATIONAL
2011-05-31
2014-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Study purpose The purpose of this study is to test the hypothesis that the monitoring of specific clinical parameters, obtained by remote controls of ICD-CRT could improve clinical course of patients with heart failure.
Study design This is a prospective observational study, comparing clinical course of patients with heart failure having an ICD-CRT implanted, followed or not by remote monitoring. This study will include 870 subjects with ICD and CRT-D, and followed by a remote monitoring system (with or without weight and pressure external sensors) or followed by conventional ambulatory visits.
Primary endpoints The primary endpoint of this study is to document no superiority of unplanned hospital access for cardiac reasons (included access to the emergency units ) or death for cardiovascular causes in remote monitoring group (with or without weight and pressure external sensors) compared to conventional follow-up (usual care group).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Benefits in Optimized Remote HF Patient Management
NCT01482598
Efficacy, Safety and Cost of Remote Monitoring of Patients With Cardiac Resynchronization Therapy
NCT03012490
TReatment of Atrial Fibrillation With Dual dEfibrillator in Heart Failure Patients
NCT00345592
Cardiac Resynchronization Therapy (CRT) Based Heart Failure Monitoring Study
NCT00632372
Heart Failure Study of Multi-site Pacing Effects on Ventriculoarterial Coupling
NCT03189368
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The clinical benefit will be assessed by:
* Increased cardiovascular events (death, myocardial infarction, hospitalization).
* Events arrhythmia: atrial fibrillation, sustained and nonsustained ventricular tachycardia or ventricular fibrillation.
* Autonomic profile, echocardiographic parameters, 6-minute walk test, quality of life questionnaire.
The primary endpoint of this study is to estimate the incidence (and its accuracy) of the first event of unplanned hospitalizations for cardiac reasons or death from cardiovascular causes in the group monitored using RPM (with or without external sensors) and in the group management via conventional follow-up (Usual Care).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Conventional
Patients with heart failure having an ICD-CRT implanted, followed by conventional visits.
No interventions assigned to this group
Remote Monitoring
Patients with heart failure having an ICD-CRT implanted, followed by remote monitoring.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients implanted or eligible for implant with ICD-CRT-D, accordingly with guidelines of the centers, for heart failure treatment and/or primary prevention of sudden death
Exclusion Criteria
* Myocardial infarction within 2 months before enrolment.
* Significant concurrent illness or condition severely limiting life expectancy.
* Any surgical or medical condition which, at the discretion of the investigator, place the patient at higher risk from his/her participation in the study, or are likely to prevent the patient from complying with the requirements of the study or completing the trial period.
* History of drug or alcohol abuse within the last 2 years.
* Inability to communicate and comply with all study requirements including the unwillingness or inability to provide informed consent.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Effect Group, Italy
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gianfranco Buja, MD
Role: PRINCIPAL_INVESTIGATOR
University of Padova
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ospedali riuniti di Ancona
Ancona, , Italy
Azienda Ospededaliero Universitaria Policlinico
Bari, , Italy
Ospedale di Venere
Bari, , Italy
Ospedale S.Spirito
Casale Monferrato, , Italy
Ferrari Hospital
Casarano, , Italy
Presidio Ospedaliero Ferrari
Castrovillari, , Italy
Policlinico V,Emanuele - Cardiologia Ferrarotto
Catania, , Italy
Fondazione Istituto San Raffaele G.Giglio
Cefalù, , Italy
Dep. of Cardiology, Civic Hospital
Cirié, , Italy
Vito Fazzi Hospital
Lecce, , Italy
Civic Hospital
Moncalieri, , Italy
Ospedale dei Colli - Monaldi
Napoli, , Italy
Clinica Mediterranea
Napoli, , Italy
Ospedale dei Colli, Monaldi
Napoli, , Italy
Dept. Cardiology, S. Cuore Hospital
Negrar, , Italy
Dipartimento di Scienze Cardiologiche, Toraciche e Vascolari-Università di Padova
Padua, , Italy
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Capucci A, De Simone A, Luzi M, Calvi V, Stabile G, D'Onofrio A, Maffei S, Leoni L, Morani G, Sangiuolo R, Amellone C, Checchinato C, Ammendola E, Buja G. Economic impact of remote monitoring after implantable defibrillators implantation in heart failure patients: an analysis from the EFFECT study. Europace. 2017 Sep 1;19(9):1493-1499. doi: 10.1093/europace/eux017.
De Simone A, Leoni L, Luzi M, Amellone C, Stabile G, La Rocca V, Capucci A, D'onofrio A, Ammendola E, Accardi F, Valsecchi S, Buja G. Remote monitoring improves outcome after ICD implantation: the clinical efficacy in the management of heart failure (EFFECT) study. Europace. 2015 Aug;17(8):1267-75. doi: 10.1093/europace/euu318. Epub 2015 Apr 4.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Effect
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.